- Home
- BTAI vs GMM Comparison
BTAI vs GMM Comparison
Compare BTAI & GMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BTAI | GMM |
|---|---|---|
| Founded | 2017 | 2017 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.2M | 39.6M |
| IPO Year | 2018 | 2023 |
Fundamental Metrics
Financial Performance| Metric | BTAI | GMM |
|---|---|---|
| Price | $1.60 | $1.17 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $32.80 | N/A |
| AVG Volume (30 Days) | ★ 463.9K | 29.3K |
| Earning Date | 11-12-2025 | 08-18-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.79 |
| Revenue | $752,000.00 | ★ $48,171,048.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $441.98 | N/A |
| P/E Ratio | ★ N/A | $0.66 |
| Revenue Growth | N/A | ★ 41.74 |
| 52 Week Low | $1.17 | $0.94 |
| 52 Week High | $9.26 | $4.97 |
Technical Indicators
Market Signals| Indicator | BTAI | GMM |
|---|---|---|
| Relative Strength Index (RSI) | 36.65 | 34.17 |
| Support Level | $1.50 | $0.94 |
| Resistance Level | $1.89 | $1.36 |
| Average True Range (ATR) | 0.11 | 0.11 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 13.77 | 48.78 |
Price Performance
Historical ComparisonAbout BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About GMM Global Mofy Metaverse Limited
Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.